Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death

Author:

Finocchiaro Gherardo12,Sheikh Nabeel12,Leone Ornella3ORCID,Westaby Joe4,Mazzarotto Francesco5678,Pantazis Antonis8,Ferrantini Cecilia910,Sacconi Leonardo1011ORCID,Papadakis Michael4ORCID,Sharma Sanjay4ORCID,Sheppard Mary N4,Olivotto Iacopo5

Affiliation:

1. Cardiothoracic Centre, Guy’s and St Thomas’ Hospital, London, UK

2. King’s College London

3. Cardiovascular and Cardiac Transplant Pathology Unit, Department of Pathology, Sant’Orsola-Malpighi University Hospital, Bologna, Italy

4. Cardiovascular Pathology Unit and Cardiology Clinical and Academic Group. St George’s, University of London, London and St George’s University Hospital NHS Foundation Trust, UK

5. Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy

6. Department of Experimental and Clinical Medicine, University of Florence, Italy

7. National Heart and Lung Institute, Imperial College London, UK

8. Cardiovascular Research Centre, Royal Brompton and Harefield National Health Service Foundation Trust, London, UK

9. University of Florence, Florence, Italy

10. European Laboratory for Non-Linear Spectroscopy, Florence, Italy

11. Institute for Experimental Cardiovascular Medicine, University of Freiburg, Freiburg, Germany

Abstract

Abstract Myocardial disarray is defined as disorganized cardiomyocyte spatial distribution, with loss of physiological fibre alignment and orientation. Since the first pathological descriptions of hypertrophic cardiomyopathy (HCM), disarray appeared as a typical feature of this condition and sparked vivid debate regarding its specificity to the disease and clinical significance as a diagnostic marker and a risk factor for sudden death. Although much of the controversy surrounding its diagnostic value in HCM persists, it is increasingly recognized that myocardial disarray may be found in physiological contexts and in cardiac conditions different from HCM, raising the possibility that central focus should be placed on its quantity and distribution, rather than a mere presence. While further studies are needed to establish what amount of disarray should be considered as a hallmark of the disease, novel experimental approaches and emerging imaging techniques for the first time allow ex vivo and in vivo characterization of the myocardium to a molecular level. Such advances hold the promise of filling major gaps in our understanding of the functional consequences of myocardial disarray in HCM and specifically on arrhythmogenic propensity and as a risk factor for sudden death. Ultimately, these studies will clarify whether disarray represents a major determinant of the HCM clinical profile, and a potential therapeutic target, as opposed to an intriguing but largely innocent bystander.

Funder

The European Union’s Horizon 2020 Research and Innovation Programme

SILICOFCM - In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy

Italian Ministry of Health

Left ventricular hypertrophy in aortic valve disease and hypertrophic cardiomyopathy: genetic basis, biophysical correlates and viral therapy models

Ente Cassa di Risparmio di Firenze

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3